Depression: Doctors Are Turning to Ketamine for Treatment | Time.com

There hasn’t been a major depression-drug breakthrough in nearly three decades, but a number of factors are conspiring to change that. Scientists are gaining a more nuanced picture of what depression is–not a monolithic disease, but probably dozens of distinct maladies–and they’re getting closer to learning what works for which kind of ailment.

Source: Depression: Doctors Are Turning to Ketamine for Treatment | Time.com

Share

Can exercise cure depression and anxiety? – The Washington Post

Please note that the writer of this article should not have used the word “cure.” Exercise is a treatment for depression, not a cure. There is no cure for depression at this time. Also, your depression treatment should always be under the care of a doctor, whether medication, therapy or exercise. – Editor

At the age of 16, Heather Troupe received a diagnosis of chronic severe depression and a prescription for an antidepressant. Eight years and 20 pounds later, she was sleeping poorly, felt a lot of anxiety and had lost her therapist because of insurance complications. Looking to “fix herself,” as Troupe, of Knoxville, Tenn., put it, she began using an elliptical machine every day at the gym, hoping to sweat away what was ailing her. Today, Troupe, 33, has been medication-free for nine years and credits her daily exercise habits with helping her achieve mental health.

Read on: Can exercise cure depression and anxiety? – The Washington Post

Share

Talk Therapy May Help Depressed Teens Who Shun Antidepressants

(HealthDay News) — Depressed teens who refuse antidepressants may benefit from counseling, a new study suggests.The study included more than 200 teens who were unwilling to take medication to treat their depression. The researchers found that those who tried a type of short-term “talk therapy” — known as cognitive behavioral therapy (CBT) — were more likely to recover than those who didn’t.”High numbers of adolescents experience depression, as many as 10 to 15 percent each year — and up to one in five by age 18,” said lead researcher Greg Clarke. He is a depression investigator at the Kaiser Permanente Center for Health Research in Portland, Ore.”Unfortunately, most of these depressed teens are not treated. As few as 30 percent get specific depression care,” he said.In many cases, depressed teens refuse to take antidepressants, “often because of side effect concerns,” Clarke said. These include warnings going back to 2004 about suicidal thoughts and behavior related to antidepressant use, the researchers said. Other common side effects from antidepressants include weight gain and fatigue.”Offering brief cognitive behavioral therapy is an effective alternative,” Clarke said. The small to moderate benefits found in this trial may be tied to reduced need for psychiatric hospitalization, the researchers noted.

Source: Talk Therapy May Help Depressed Teens Who Shun Antidepressants

Share

Exercise Might Lift Libido in Women on Antidepressants

(HealthDay News) — Exercise might help treat sexual problems in women taking antidepressants, especially if their workouts occur right before sex, new research reveals.

The study included 52 women who had reduced desire and other sexual side effects while taking antidepressants.

For the first three weeks of the study, the women did not exercise. They were then divided into two groups for the next three weeks, with one group assigned to exercise immediately before sex and the other group assigned to exercise in a way that was not timed to having sex. The researchers then reversed the two groups for another three weeks.

via Exercise Might Lift Libido in Women on Antidepressants.

Share

Lilly says depression drug didn’t meet goal in three studies – chicagotribune.com

Eli Lilly & Co. will end development of the depression medicine edivoxetine as an add-on therapy after the drug failed to meet goals in three studies.A current trial evaluating the experimental compound’s long-term effects will continue, the Indianapolis-based company said in a statement Thursday. Edivoxetine was in the final of three stages of testing usually required for marketing approval by U.S. regulators.

via Lilly says depression drug didn't meet goal in three studies – chicagotribune.com.

Share